Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly used medications in the world. NSAID-induced adverse reactions involve upper gastrointestinal (GI) tract complications, which can be life-threatening. Objectives: The study was conducted to explore the current prescription pattern of non-steroidal anti-inflammatory drugs (NSAIDs) and the prevalence of NSAID-induced gastrointestinal(GI) risk factors of orthopedic adult inpatient.Materials and methods: A prospective observational NSAIDs induced GI risk related study was conducted over a period of 6 months by clinical pharmacist. Study cohort included 105 orthopaedic inpatients who are taking or will be taking NSAIDs for more than a week. A selfadministered questionnaire was completed by each patient. A simplified risk scoring scale (the Standardized Calculator of Risk for Events; SCORE) was used to measure patients" risk for GI complications. The pattern of NSAIDs prescription was identified from medical recordings.Results: The study groups were stratified into four risk groups according to GI SCORE tool, 27.6% of the patients belonged to high risk or very high risk groups for GI complications. Analysis of prescription pattern revealed that 11.4% of the patients aged over 65 yr, 19% with co morbid disease were prescribed with COX-2 selective inhibitor. Conclusion: In this study assessment of prescription pattern and GI risk factors for NSAIDs were evaluated and in conclusion, physician"s considerate prescription of NSAIDs with wellunderstanding of each patient"s GI risk factors is strongly encouraged to prevent serious GI complications
Introduction
Although there are many definitions of an ADR, an internationally accepted description is that of the World Health Organization (WHO): ""A response to a drug that is noxious and unintended, and that occurs at doses normally used in humans for the prophylaxis, diagnosis, or therapy of disease or for the modification of physiological function". The NSAIDs are a group of chemically dissimilar agents that differ in their antipyretic, analgesic, and anti-inflammatory activities. GI complications occur in 1%-5% of patients taking NSAIDs for more than one year and result in high costs and mortality. Rates of GI complications may vary substantially depending on each patient"s clinical characteristics. Identification of the NSAID-related GI risk factors is therefore crucial in determining the proper treatment for each patient. Many studies already reported that the development of serious GI complications are highly correlated with certain factors, including health status of disability, increasing age, concomitant use of systemic steroids or anticoagulants, history of a GI ulcer of bleed, diagnosis of rheumatoid arthritis, certain patterns of prior NSAID use, history of cardiovascular disease, smoking status, and NSAID-related GI symptoms . Prior to market release of the first cyclooxygenase-2 enzyme(COX-2) selective inhibitor (celecoxib), northern California health maintenance organization (HMO) developed 
Materials and methods
The study was conducted in a multispecialty tertiary care hospital, in the department of orthopedics. A total of 105 patients were enrolled in the study. The study was designed to be a prospective observational study, carried out in single center for a period of 6 months. The sample population was selected by inclusion-exclusion criteria. Adult in-patients of orthopedic department who have used or will be using NSAIDs for more than a week were included Patients with difficulty in answering questionnaire and patients who are unwilling to participate in the study are excluded from the study. Table  7 ]. When the type of prescription was analyzed in overall study groups, Lornoxicam was the most commonly used NSAID, comprising 51.4% of the patients. Etoricoxib (32.3%), Diclofenac (14.2%), Aceclofenac( 11.4%), Piroxicam (3.8%), Ibuprofen ( 2.8%), Aspirin (2%) were followed consecutively. [ Table 5 ].Analysis of prescription pattern revealed that only 19% of patients with co morbid diseases( cardiovascular, renal, hepatic diseases, diabetes mellitus, hypertension etc) , 11.4% of patients aged over 65 yrs , 7.6% of patients with current poor health status ,6.6% of patients with concomitant anticoagulant use, 3.8 % of patients with history of GI symptom, 2 % of patients using SSRIs , 1 % of patients with heavy smoking and drinking habit to decrease the risk of GI complications by prescribing selective COX-2 inhibitors.[ Table 6 ].Analysis of the measures taken to reduce the GI risk shows 89% of patients were prescribed with proton pump inhibitor and the rest 11% were on H 2 receptor antagonist [ Table 8 ]
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Distribution based on Prescription pattern of COX-2 inhibitor according to the GI risk factors
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The figure depicts the prescription patterns on COX-2 inhibitors based on GI risk factors Distribution of sample population based on GI score 
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This figure shows the percentage distribution of the study population based on the drugs used to prevent NSAID induced GI risk
Discussion
All the individuals participated in the study (105) were grouped according to their gender for analysis as figure 5 . Analysis of prescription pattern revealed that only 6.6% of patients with concomitant anticoagulant use, 11.4% of the patients aged over 65 yr, 19% with comorbid disease were prescribed COX-2 selective inhibitor to decrease the risk of developing GI complications (table 6 and figure 6). In table 7 and figure 7, the study groups were stratified into four risk groups according to GI SCORE tool, 38.1% belongs to low risk,34.3% of the patients belonged to moderate risk, 19% belongs to high risk and 8.6% belongs to very high risk.In table 8 and figure 8 ,the study groups were stratified based on drugs prescribed to reduce NSAID induced GI risk.89% of patients were prescribed with proton pump inhibitor and the rest 11% were on H 2 receptor antagonist.
Conclusion
During the study period, most of the risk factors which caused NSAID induced GI problems were analyzed and the prescription pattern of both selective and non-selective COX inhibitors is analyzed. According to the GI SCORE tool 27.6% of patients falls in high risk or very high risk category, the use of selective COX -2 inhibitors are strongly encouraged. A well-understanding of each patient"s GI risk factors is necessary in order to maximize cost effectiveness and to prevent serious GI complications.
